Expression and functional analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 isozymes

Drug Metabolism and Disposition

Volumn 37, Issue 1, 2009, Pages 1-4

  Zhang, Wei Yan ^a,b   Tu, You Bin ^a   Haining, Robert L ^a   Yu, Ai Ming ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CODEIN O DEMETHYLASE; CODEINE; COMPLEMENTARY DNA; CYTOCHROME P450 2D6; CYTOCHROME P450 2D6.24; CYTOCHROME P450 2D6.26; CYTOCHROME P450 2D6.27; CYTOCHROME P450 2D7; DEXTROMETHORPHAN; DRUG METABOLIZING ENZYME; ISOENZYME; MORPHINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; DEMETHYLATION; DNA POLYMORPHISM; ENZYME ACTIVITY; GENETIC VARIABILITY; INSECT CELL; MICROSOME; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ALLELES; BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; HUMANS; ISOENZYMES; KINETICS; MUTAGENESIS, SITE-DIRECTED;

HEXAPODA;

EID: 58149476927     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.023663     Document Type: Article

References (26)

1. Bhathena A, Mueller T, Grimm DR, Idler K, Tsurutani A, Spear BB, and Katz DA (2007) Frequency of the frame-shifting CYP2D7 138deIT polymorphism in a large, ethnically diverse sample population. Drug Metab Dispos 35:1251-1253.
2. Felmlee MA, Lon HK, Gonzalez FJ, and Yu AM (2008) Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice. Drug Metab Dispos 36:435-441.
3. *36 with poor metabolizer status. Drug Metab Dispos 34:563-569.
4. Gaedigk A, Gaedigk R, and Leeder JS (2005) CYP2D7 splice variants in human liver and brain: does CYP2D7 encode functional protein? Biochem Biophys Res Commun 336:1241-1250.
5. Gaedigk A, Simon SD, Pearce RE, Bradford LD, Kennedy MJ, and Leeder JS (2008) The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin Pharmacol Ther 83:234-242.
6. Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, and Meyer UA (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331:442-446.
7. Gonzalez FJ and Yu AM (2006) Cytochrome P450 and xenobiotic receptor humanized mice. Annu Rev Pharmacol Toxicol 46:41-64.
8. Haining RL, Hunter AP, Veronese ME, Trager WF, and Rettie AE (1996) Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms. Arch Biochem Biophys 333:447-458.
9. Johansson I, Oscarson M, Yue QY, Bertilsson L, Sjöqvist F, and Ingelman-Sundberg M (1994) Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol Pharmacol 46:452-459.
10. Kimura S, Umeno M, Skoda RC, Meyer UA, and Gonzalez FJ (1989) The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet 45:889-904.
11. Klein K, Tatzel S, Raimundo S, Saussele T, Hustert E, Pleiss J, Eichelbaum M, and Zanger UM (2007) A natural variant of the heme-binding signature (R441C) resulting in complete loss of function of CYP2D6. Drug Metab Dispos 35:1247-1250.
12. *56 allele identified by genotype/phenotype analysis of cryopreserved human hepatocytes. Drug Metab Dispos 34:1411-1416.
13. *35 allele in ultrarapid metabolism? Pharmacogenetics 11:45-55.
14. Marez D, Legrand M, Sabbagh N, Guidice JM, Spire C, Lafltte JJ, Meyer UA, and Broly F (1997) Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogeneucs 7:193-202.
15. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
16. Pai HV, Kommaddi RP, Chinta SJ, Mori T, Boyd MR, and Ravindranath V (2004) A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine. J Biol Chem 279:27383-27389.
17. Shen H, He MM, Liu H, Wrighton SA, Wang L, Guo B, and Li C (2007) Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17. Drug Metab Dispos 35:1292-1300.
18. Snider NT, Sikora MJ, Sridar C, Feuerstein TJ, Rae JM, and Hollenberg PF (2008) The endocanuabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. J Pharmacol Exp Ther 327:538-545.
19. *59) leading to impaired expression and function of CYP2D6. Phannacogenet Genomics 16:767-770.
20. Yu A, Dong H, Lang D, and Haining RL (2001) Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recolnbinant human CYP2D6. Drug Metab Dispos 29:1362-1365.
21. Yu A, Kneller BM, Rettie AE, and Haining RL (2002) Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms. J Pharmacol Exp Ther 303:1291-1300.
22. Yu AM and Haining RL (2006) Expression, purification, and characterization of mouse CYP2d22. Drug Metab Dispos 34:1167-1174.
23. Yu AM, Idle JR. Byrd LG, Krausz KW, Kupfer A, and Gonzalez FJ (2003a) Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYT2D6. Pharmacogenetics 13:173-181.
24. Yu AM, Idle JR, and Gonzalez FJ (2004) Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates. Drug Metab Rev 36:243-277.
25. Yu AM, Idle JR, Herraiz T, Kupfer A, and Gonzalez FJ (2003b) Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. Pharmacogenetics 13:307-319.
26. Zanger UM, Raimundo S, and Eichelbaum M (2004) Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol 369:23-37.